- Home
- SD vs CDXS Comparison
SD vs CDXS Comparison
Compare SD & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SD
- CDXS
- Stock Information
- Founded
- SD 2006
- CDXS 2002
- Country
- SD United States
- CDXS United States
- Employees
- SD N/A
- CDXS N/A
- Industry
- SD Oil & Gas Production
- CDXS Major Chemicals
- Sector
- SD Energy
- CDXS Industrials
- Exchange
- SD Nasdaq
- CDXS Nasdaq
- Market Cap
- SD 444.3M
- CDXS 406.9M
- IPO Year
- SD 2007
- CDXS 2010
- Fundamental
- Price
- SD $12.39
- CDXS $5.13
- Analyst Decision
- SD
- CDXS Buy
- Analyst Count
- SD 0
- CDXS 2
- Target Price
- SD N/A
- CDXS $11.00
- AVG Volume (30 Days)
- SD 299.2K
- CDXS 739.7K
- Earning Date
- SD 03-05-2025
- CDXS 02-26-2025
- Dividend Yield
- SD 3.54%
- CDXS N/A
- EPS Growth
- SD N/A
- CDXS N/A
- EPS
- SD 1.27
- CDXS N/A
- Revenue
- SD $120,243,000.00
- CDXS $64,446,000.00
- Revenue This Year
- SD N/A
- CDXS N/A
- Revenue Next Year
- SD $43.19
- CDXS $2.02
- P/E Ratio
- SD $9.75
- CDXS N/A
- Revenue Growth
- SD N/A
- CDXS N/A
- 52 Week Low
- SD $10.31
- CDXS $2.53
- 52 Week High
- SD $15.31
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- SD 63.63
- CDXS 58.39
- Support Level
- SD $11.87
- CDXS $4.24
- Resistance Level
- SD $12.69
- CDXS $5.51
- Average True Range (ATR)
- SD 0.35
- CDXS 0.32
- MACD
- SD 0.08
- CDXS 0.00
- Stochastic Oscillator
- SD 81.95
- CDXS 82.68
About SD SandRidge Energy Inc.
SandRidge Energy Inc is a United States-based oil and natural gas company. It is engaged in the exploration, development, and production of crude oil, natural gas, and Natural gas liquids. Business activities of the group include Exploration and Production, Drilling and Oil Field Services, and Midstream Gas Services.
About CDXS Codexis Inc.
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.